Overview

Antioxidation Medication for Noise-induced Hearing Loss

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This study will examine whether oral intake of 1200mg N-Acetylcysteine/day will prevent temporary threshold shift in hearing among workers exposed to noise
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborators:
Institute of Occupational Safety and Health, Taiwan
Municipal Hospital of Tainan, Taiwan
Treatments:
Acetylcysteine
N-monoacetylcystine